# Pioglitazone to Treat Opioid Withdrawal Symptoms

> **NCT01517165** · PHASE1 · TERMINATED · sponsor: **National Institute on Drug Abuse (NIDA)** · enrollment: 24 (actual)

## Conditions studied

- Opioid-Related Disorders

## Interventions

- **DRUG:** Pioglitazone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01517165
- **Lead sponsor:** National Institute on Drug Abuse (NIDA)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-01-04
- **Primary completion:** 2015-02-02
- **Final completion:** 2015-02-02
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2018-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01517165

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01517165, "Pioglitazone to Treat Opioid Withdrawal Symptoms". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01517165. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*